Morgan Stanley
CDIO icon

Morgan Stanley’s Cardio Diagnostics CDIO Stock Holding History

Morgan Stanley’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195 Hold
100
– – ﹤0.01% 7698
2025
Q4 		$271 Sell
100
-23
-19% -$84 ﹤0.01% 7597
2025
Q3 		$493 Buy
123
+23
+23% +$91 ﹤0.01% 7497
2025
Q2 		$360 Sell
100
-50
-33% -$374 ﹤0.01% 7496
2025
Q1 		$1.49K Buy
150
+50
+50% +$779 ﹤0.01% 7232
2024
Q4 		$2.75K Buy
100
+67
+203% +$929 ﹤0.01% 7137
2024
Q3 		$223 Buy
+33
New +$405 ﹤0.01% 7376
2023
Q1 		– Hold
0
– -$3 – 7728
2022
Q4 		– Hold
0
– – – 7845

Other funds holding CDIO

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley's CDIO Position: Q1 2026 in Review

Morgan Stanley held its Cardio Diagnostics (CDIO) position steady in Q1 2026 at 100 shares worth $195. The position accounts for ﹤0.01% of the portfolio, ranked #7698.

Morgan Stanley first reported a position in CDIO in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.75K in Q4 2024. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

  • Morgan Stanley held 100 shares of Cardio Diagnostics worth $195 as of Q1 2026.
  • Morgan Stanley left its Cardio Diagnostics share count unchanged in Q1 2026.
  • Cardio Diagnostics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7698 holding.
  • Morgan Stanley first reported a position in Cardio Diagnostics in Q3 2024 and has held it in 7 quarters since.
  • Morgan Stanley's Cardio Diagnostics position peaked at $2.75K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.